Anticoagulant therapy during pregnancy in patients with mechanical valvular prostheses;Conduite du traitement anticoagulant pendant la grossesse chez les patientes ayant une prothèse mécanique

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 10, 2001, Pages 1073-1076

  Hanania, G ^a   Nassivera, L ^a  

^a Centre hospital Robert Ballanger   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN ANTICOAGULANT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BLEEDING; EMBRYOPATHY; HEART VALVE PROSTHESIS; HUMAN; PREGNANCY; REVIEW; THROMBOEMBOLISM; THROMBOSIS;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICOAGULANTS; FEMALE; HEART VALVE PROSTHESIS; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; THROMBOEMBOLISM;

EID: 18344403374     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Maternal and fetal sequelae of anticoagulation during pregnancy
2. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses
3. Guidelines for prevention of thromboembolic events in valvular heart disease: Study group of the working group on valvular heart disease of the European society of cardiology
4. ACC/AHA Guidelines for the management of patients with valvular heart disease
5. Grossesse chez les porteuses de prothèse valvulaire. Etude coopérative rétrospective française (155 cas)
6. Outcome of pregnancy in women with valve prostheses
7. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses
8. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
9. Dose-dependent fetal complications of Warfarin in pregnant women with mechanical heart valves
10. AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves
11. Low molecular weight heparin versus unfractionated heparin after mechanical heart valve replacement
12. Management of pregnancy in women with thrombophilia
13. Safely of low-molecular-weight heparin in pregnancy a systematic review
14. A european view on the north american fifth consensus on antithrombotic therapy
15. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement
16. Low molecular weight heparin in a pregnant woman with mechanical heart valve prosthesis: A case report
17. Low molecular weight heparin for prosthetic heart valves: Treatment failure